Search published articles


Showing 5 results for Khara

Sadegipoor Hr, Eftekharardabili H, Zeraati H, Mosleh A,
Volume 61, Issue 4 (15 2003)
Abstract

This research studies the quality of medical prescriptions for children under 5 years of age and their effective factors carried out by Behvarzes at Eslamshar town.
Materials and Methods: The study took place in 19 health houses considering the medical family files of patient children seeking for medical care by 33 Behvarz for quality of medical prescription. Two questionnaire were used for the study. The first questionnaire contained information about children medical prescription and variables evaluated in relation to medical prescription dose, duration of consumption and the cure duration period, which carried out for both girl and boy group separately. The second questionnaire contained information about the condition of working Behvarzes demographic in health houses considered variable for Behvarzes are: Age, Sex , experience, education, place of residence marital status.
Results: The important points of the study are as follow: - In cases that according to Behvarzy training patient follow up is necessary, 56.9%of the needed cases did not full fill the appropriate and necessary follow up program. - One of the important constraints of the research is the high percent of unrecorded cases by Behvarzes including:
1 - 1.2% unknown medical prescriptions.
2- 44.2% unknown dose of prescribed medicine
3- 52.4% unknown care duration period
4- 36.5% unknown period of time for taking the medicine. Conclusion: According to the information:

1- 64.9 dose of prescribed medicine
2- 73.2 period of time for taking the medicine
3- 84.1 care duration period There were appropriate.


Bokharaei-Salim F, Keyvani H, Zamani F, Jahanbakhsh Sefidi F, Amiri A,
Volume 69, Issue 10 (5 2012)
Abstract

Normal 0 false false false EN-US X-NONE AR-SA MicrosoftInternetExplorer4 Background: Hepatitis C virus (HCV) is essentially considered as hepatotropic, but virus sequences have also been found in other important extrahepatic sites, including peripheral blood mononuclear cells (PBMCs). This study was done to investigate the presence of mixed infection and the differences between hepatitis C virus genotypes in plasma, peripheral blood mononuclear cells, and liver biopsy specimens in patients with hepatitis C virus infection.
Methods : One hundred and fifty two patients with established chronic hepatitis C infection attending Firouzgar Hospital, affiliated to Tehran University of Medical Sciences, from September 2008 to April 2010 were enrolled in the present study. After collecting plasma, peripheral blood mononuclear cell, and liver biopsy specimens, RNA was extracted from the samples and hepatitis C virus genotyping was performed using INNO-LiPATM HCV II kit. The hepatitis C virus genotyping was confirmed by sequencing the RT-nested PCR product of 5'-UTR fragments.
Results : The mean age of the participants was 31.2±16.9 years. Multiple hepatitis C virus genotypes were detected in 4 (2.6%) out of 152 plasma samples, 10 (6.6%) out of 152 peripheral blood mononuclear cell samples, and 9 (18.8%) out of 48 liver biopsy specimens. Hepatitis C virus genotypes were different in the plasma, PBMC, and liver biopsy specimens of 21 (13.8%) patients.
Conclusion: The present study shows that a significant proportion of patients with chronic hepatitis C infection are infected by multiple hepatitis C virus genotypes which may not be detectable in their plasma specimens.


Mehrdad Khatami, Sam Kharazi , Zeinab Kishani Farahani , Hakim Azizi , Marcos Augusto Lima Nobre,
Volume 75, Issue 1 (April 2017)
Abstract

Background: The modern science of nanotechnology is an interdisciplinary science that has contributed to advances in cancer treatment. This study was performed to evaluate the therapeutic effects of biosynthesized silver nanoparticles on breast cancer cell of line MCF-7 in vitro.

Methods: This analytical study was performed in Kerman and Bam University of Medical Sciences, Bam City, Kerman Province, Iran from March 2015 to March 2016. Silver nanoparticles suspension was synthesized using palm kernel extract. The resulting silver nanoparticles were studied and characterized. The ultraviolet-visible spectroscopy and transmission electron microscopy used for screening of physicochemical properties. The average particle size of the biosynthesized silver nanoparticles was determined by transmission electron microscopy. The properties of different concentrations of synthesized silver nanoparticles (1 to 3 μg/ml) and palm kernel extract (containing the same concentration of the extract was used for the synthesis of silver nanoparticles) against MCF-7 human breast cancer cells were determined by MTT assay. MTT is used to assess cell viability as a function of redox potential. Actively respiring cells convert the water-soluble MTT to an insoluble purple formazan.

Results: The ultraviolet-visible spectroscopy showed strong absorption peak at 429 nm. The X-ray diffraction (XRD) and transmission electron microscopy (TEM) images revealed the formation of silver nanoparticles with spherical and octagon shape and sizes in the range between 1-40 nm, with an average size approximately 17 nm. The anti-cancer effect of silver nanoparticles on cell viability was strongly depends on the concentration of silver nanoparticles and greatly decrease with increasing the concentration of silver nanoparticles. The IC50 amount of silver nanoparticle was 2 μg/ml.

Conclusion: The biosynthesized silver nanoparticles showed a dose-dependent toxicity against MCF-7 human breast cancer cells.


Kamran Aghakhani , Seyyed Hossein Eslami , Afshin Khara , Mohsen Bijandi ,
Volume 76, Issue 7 (October 2018)
Abstract

Head injury is one of the most important types of injury and is responsible for most of the deaths due to trauma. Low-income and middle-income countries face with more risk factors, but they still lack adequate health-care capacity to deal with complications. Trauma literally means the damage and injury, and head injury was defined as physical damage to the brain or skull caused by external forces. Head trauma is an important event. Anyone can fall including toddlers, adults and elders. There are several mechanisms for head injury, including motor vehicle accidents, falls, assault and violence. After the motor vehicle accidents, fall is the second most important cause of head injury. Deaths from falling in countries with lower socioeconomic conditions are higher. To collect the information for this study, the PubMed, Scopus and Google Scholar databases were used. Sixty-four related articles were reviewed from 1980 to 2018. The keywords including "head injury", "head trauma", "brain damage", "fall mechanism", "Iran" and "epidemiology" were used to search the articles. According to the findings of this review fall is the second most common head injury mechanism in Iran. The fall mechanism is more common in the age group of young children and elderly. Also, the incidence of fall mechanism is more in males with head injury than women. In most other countries in the world, fall is the first and the second head injury mechanism. Also, falling from lower altitudes is a more common mechanism than a fall from higher altitude in injury to the head. Falling from lower level is a more common mechanism than fall from higher level in head injuries. In addition, the outbreak of the fall mechanism in children and the elderly with head injuries is more. Despite the efforts that have been made in the past years to determine the pattern of epidemiology of head trauma and its results in Iran, there is not enough information on fall-related head injury. Considering that the head traumatic injury is one of the most common and most dangerous outcomes of fall, the purpose of this review study is to investigate epidemiologic fall-related head injury.

Ahmad Tavakoli , Maryam Esghaei , Angila Ataei-Pirkooh , Mohsen Moghoofei , Hadi Ghaffari , Farah Bokharaei-Salim ,
Volume 77, Issue 5 (August 2019)
Abstract

Currently, there are about 37 million people worldwide living with human immunodeficiency virus (HIV) /AIDS, with an estimated two million new cases per year globally. According to estimates from the World Health Organization (WHO), only 75% of the population with HIV know their status. Initially, HIV infection was associated with significantly increased rates of mortality and morbidity. However, the rapid advances in treatment and the advent of different classes of antiretroviral drugs over time have led to change the face of HIV/AIDS from a deadly infection to chronic and manageable disease. There is strong evidence that HIV-infected patients undergoing antiretroviral therapy have longer lives and are less likely to transmit infection to their sexual partners. Since the introduction of zidovudine in 1987 as the first antiretroviral drug, significant strides have been made in antiretroviral therapy. The introduction of potent antiretroviral drugs for the treatment of HIV infection has been one of the significant events in the evolution of modern medicine. Antiretroviral therapy refers to the use of drugs in the treatment of HIV. Generally, these drugs are categorized based on the steps of the HIV life cycle suppressed by them. There are six main classes of antiretroviral agents including nucleoside/ nucleotide reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors, co-receptor inhibitors, and integrase inhibitors. Combination antiretroviral therapy should be considered for HIV patients to achieve the highest viral suppression rate, and to reduce the risk of resistance development and morbidity and mortality associated with AIDS. Achieving and maintaining HIV viral load suppression among treated patients has remarkably increased over the last years due to the development of potent and well-tolerated agents which can be co-formulated as a once-daily single-tablet or fixed-dose combination for simplification. However, there are some limitations preventing patients to benefit from this treatment. The main goals of HIV therapy in the future are to overcome the limitations of current treatment, including side effects. This review will provide an overview of advances in the current antiretroviral drugs by focusing on their pharmacokinetics, mechanism of action, dosing recommendations, and adverse events for each drug class.


Page 1 from 1     

© 2025 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by : Yektaweb